Giving RFK Jr. control of HHS would be disastrous: an Editor’s Commentary

The pharma CEOs, lobbyists and hedge fund managers who confidently reassured me and anyone who would listen that they had an inside track to Trumpland, and that he wouldn’t nominate Robert F. Kennedy Jr. for an influential position, were wrong. It turns out that people who said they had spoken with Trump personally, to his transition team, to his advisers or to his golf caddie were just hearing what they wanted to hear.

Apparently so was Howard Lutnick, CEO of Canter Fitzgerald and co-chair of Trump’s transition team, who said in an interview with CNN on Oct. 31 that Kennedy wasn’t in line for a position at HHS. More about that interview below. ...